CTRV - コントラビ―・ファ―マシュ―ティカルズ (ContraVir Pharmaceuticals Inc.) コントラビ―・ファ―マシュ―ティカルズ

 CTRVのチャート


 CTRVの企業情報

symbol CTRV
会社名 Contravir Pharmaceuticals Inc (コントラビ―・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 ContraVir Pharmaceuticals Inc. is focused on curing hepatitis B through the combination of direct and indirect acting antiviral compounds. Its two assets tenofovir exalidex or TXL and CRV431 have complementary mechanisms of action and have shown potential synergy against hepatitis B virus (HBV). TXL is designed to deliver high intrahepatic concentrations of TFV while minimizing off target effects caused by high levels of circulating TFV and has completed a Phase IIa trial. CRV431 the other anti-HBV compound is a next generation cyclophilin inhibitor with a unique structure that increases its potency and selective index against HBV. In vitro and in vivo studies have thus far demonstrated that CRV431 reduces HBV DNA and other viral proteins including surface antigen (HBsAg).   コントラビ―・ファ―マシュ―ティカルズは、米国のバイオ医薬品会社。水痘帯状疱疹ウイルスの再活性化によって引き起こされる感染症である帯状疱疹を治療する臨床開発製薬「FV-100」に主に焦点を当てる。また水痘帯状疱疹ウイルスの再活性化によって引き起こされる感染症の帯状疱疹のための治療も開発する   ContraVir Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.
本社所在地 399 Thornall Street First Floor Edison NJ 08837 USA
代表者氏名 Gary S. Jacob ゲイリー・ジェイコブ
代表者役職名 Chairman of the Board of Directors
電話番号 +1 732-902-4000
設立年月日 41395
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 20人
url www.contravir.com
nasdaq_url https://www.nasdaq.com/symbol/ctrv
adr_tso
EBITDA EBITDA(百万ドル) -18.24716
終値(lastsale) 0.57
時価総額(marketcap) 8237593.26
時価総額 時価総額(百万ドル) 7.94855
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 8.22400
当期純利益 当期純利益(百万ドル) -13.83067
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 ContraVir Pharmaceuticals Inc revenues was not reported. Net loss totaled to $6.7M. Results are not comparable due to year end change.

 CTRVのテクニカル分析


 CTRVのニュース

   The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief  2019/07/03 11:31:07 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 2) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Coherus Biosciences Inc (NASDAQ: CHRS ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 2) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Atreca Inc (NASDAQ: BCEL )(IPOed June 20) Biopharmx Corp (NYSE: BPMX ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Nuvectra Corp (NASDAQ: NVTR ) Personalis Inc (NASDAQ: PSNL ) (IPOed June 20) Prevail Therapeutics Inc (NASDAQ: PRVL ) (IPOed June 20) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TrovaGene Inc (NASDAQ: TROV ) See Also: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Stocks In Focus Roche's Flu Medication Found Effective And Safe In Children Roche Holdings AG Basel …
   ContraVir Rebounds From Record Low On Positive FDA Feedback  2019/06/21 13:57:15 Benzinga
ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) shares have been highly volatile of late, with the promise offered by its non-alcoholic steatohepatitis drug cushioning any downside for the stock. The shares were making a strong upward move Friday from the all-time low reached in the previous trading session. What Happened ContraVir, a thinly traded nanocap biotech, said Thursday after the close the FDA has given it positive feedback in response to its pre-IND meeting about its NASH pipeline asset CRV431. The positive feedback pertained to preclinical data for CRV431, with the regulatory body agreeing with ContraVir's proposed plan for further preclinical studies to support the development of the asset. The FDA also supported … Full story available on Benzinga.com
   ContraVir's stock rockets off record low after 'positive feedback' on pre-IND for NASH  2019/06/21 11:31:00 MarketWatch
Shares of ContraVir Pharmaceuticals Inc. rocketed 69% in active premarket trading Friday, to bounce off the previous session's record low close, after the…
   The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy  2019/06/21 11:18:48 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 20) Abbott Laboratories (NYSE: ABT ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Celgene Corporation (NASDAQ: CELG ) Coherus Biosciences Inc (NASDAQ: CHRS ) DiaMedica Therapeutics Inc (NASDAQ: DMAC )( reported positive interim results from a Phase 1b study of its DM199, which is being evaluated for moderate-to-severe chronic kidney disease) Edesa Biotech Inc (NASDAQ: EDSA )(FDA gave the go ahead to start a Phase 2b trial for EB01, its lead candidate being evaluated for chronic allergic contact dermatitis) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Hologic, Inc. (NASDAQ: HOLX ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 20) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) AMAG Pharmaceuticals, Inc.
   The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge  2019/06/20 11:25:13 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 19) Abbott Laboratories (NYSE: ABT ) CareDx Inc (NASDAQ: CDNA ) CONMED Corporation (NASDAQ: CNMD ) DENTSPLY SIRONA Inc (NASDAQ: XRAY ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Merck & Co., Inc. (NYSE: MRK )(reports suggested that the company is on the look out to find a replacement for its CEO Ken Frazier) Novocure Ltd (NASDAQ: NVCR ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Zynex Inc. (NASDAQ: ZYXI ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 19) Abeona Therapeutics Inc (NASDAQ: ABEO ) CELYAD SA/ADR (NASDAQ: CYAD ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Jaguar Health Inc (NASDAQ: JAGX ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Surface Oncology Inc (NASDAQ: SURF ) Stocks In Focus DiaMedica Drug Found Safe And Effective Against Chronic Kidney Disease DiaMedica Therapeutics Inc (NASDAQ: DMAC ) announced interim results from the Phase 1b study of its DM199, which is being evaluated for moderate-to-severe chronic …
   The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief  2019/07/03 11:31:07 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 2) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Coherus Biosciences Inc (NASDAQ: CHRS ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 2) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Atreca Inc (NASDAQ: BCEL )(IPOed June 20) Biopharmx Corp (NYSE: BPMX ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Nuvectra Corp (NASDAQ: NVTR ) Personalis Inc (NASDAQ: PSNL ) (IPOed June 20) Prevail Therapeutics Inc (NASDAQ: PRVL ) (IPOed June 20) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TrovaGene Inc (NASDAQ: TROV ) See Also: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Stocks In Focus Roche's Flu Medication Found Effective And Safe In Children Roche Holdings AG Basel …
   ContraVir Rebounds From Record Low On Positive FDA Feedback  2019/06/21 13:57:15 Benzinga
ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) shares have been highly volatile of late, with the promise offered by its non-alcoholic steatohepatitis drug cushioning any downside for the stock. The shares were making a strong upward move Friday from the all-time low reached in the previous trading session. What Happened ContraVir, a thinly traded nanocap biotech, said Thursday after the close the FDA has given it positive feedback in response to its pre-IND meeting about its NASH pipeline asset CRV431. The positive feedback pertained to preclinical data for CRV431, with the regulatory body agreeing with ContraVir's proposed plan for further preclinical studies to support the development of the asset. The FDA also supported … Full story available on Benzinga.com
   ContraVir's stock rockets off record low after 'positive feedback' on pre-IND for NASH  2019/06/21 11:31:00 MarketWatch
Shares of ContraVir Pharmaceuticals Inc. rocketed 69% in active premarket trading Friday, to bounce off the previous session's record low close, after the…
   The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy  2019/06/21 11:18:48 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 20) Abbott Laboratories (NYSE: ABT ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Celgene Corporation (NASDAQ: CELG ) Coherus Biosciences Inc (NASDAQ: CHRS ) DiaMedica Therapeutics Inc (NASDAQ: DMAC )( reported positive interim results from a Phase 1b study of its DM199, which is being evaluated for moderate-to-severe chronic kidney disease) Edesa Biotech Inc (NASDAQ: EDSA )(FDA gave the go ahead to start a Phase 2b trial for EB01, its lead candidate being evaluated for chronic allergic contact dermatitis) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Hologic, Inc. (NASDAQ: HOLX ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 20) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) AMAG Pharmaceuticals, Inc.
   The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge  2019/06/20 11:25:13 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 19) Abbott Laboratories (NYSE: ABT ) CareDx Inc (NASDAQ: CDNA ) CONMED Corporation (NASDAQ: CNMD ) DENTSPLY SIRONA Inc (NASDAQ: XRAY ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Merck & Co., Inc. (NYSE: MRK )(reports suggested that the company is on the look out to find a replacement for its CEO Ken Frazier) Novocure Ltd (NASDAQ: NVCR ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Zynex Inc. (NASDAQ: ZYXI ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 19) Abeona Therapeutics Inc (NASDAQ: ABEO ) CELYAD SA/ADR (NASDAQ: CYAD ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Jaguar Health Inc (NASDAQ: JAGX ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Surface Oncology Inc (NASDAQ: SURF ) Stocks In Focus DiaMedica Drug Found Safe And Effective Against Chronic Kidney Disease DiaMedica Therapeutics Inc (NASDAQ: DMAC ) announced interim results from the Phase 1b study of its DM199, which is being evaluated for moderate-to-severe chronic …
   The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief  2019/07/03 11:31:07 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 2) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Coherus Biosciences Inc (NASDAQ: CHRS ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 2) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Atreca Inc (NASDAQ: BCEL )(IPOed June 20) Biopharmx Corp (NYSE: BPMX ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Nuvectra Corp (NASDAQ: NVTR ) Personalis Inc (NASDAQ: PSNL ) (IPOed June 20) Prevail Therapeutics Inc (NASDAQ: PRVL ) (IPOed June 20) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TrovaGene Inc (NASDAQ: TROV ) See Also: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Stocks In Focus Roche's Flu Medication Found Effective And Safe In Children Roche Holdings AG Basel …
   ContraVir Rebounds From Record Low On Positive FDA Feedback  2019/06/21 13:57:15 Benzinga
ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) shares have been highly volatile of late, with the promise offered by its non-alcoholic steatohepatitis drug cushioning any downside for the stock. The shares were making a strong upward move Friday from the all-time low reached in the previous trading session. What Happened ContraVir, a thinly traded nanocap biotech, said Thursday after the close the FDA has given it positive feedback in response to its pre-IND meeting about its NASH pipeline asset CRV431. The positive feedback pertained to preclinical data for CRV431, with the regulatory body agreeing with ContraVir's proposed plan for further preclinical studies to support the development of the asset. The FDA also supported … Full story available on Benzinga.com
   ContraVir's stock rockets off record low after 'positive feedback' on pre-IND for NASH  2019/06/21 11:31:00 MarketWatch
Shares of ContraVir Pharmaceuticals Inc. rocketed 69% in active premarket trading Friday, to bounce off the previous session's record low close, after the…
   The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy  2019/06/21 11:18:48 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 20) Abbott Laboratories (NYSE: ABT ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Celgene Corporation (NASDAQ: CELG ) Coherus Biosciences Inc (NASDAQ: CHRS ) DiaMedica Therapeutics Inc (NASDAQ: DMAC )( reported positive interim results from a Phase 1b study of its DM199, which is being evaluated for moderate-to-severe chronic kidney disease) Edesa Biotech Inc (NASDAQ: EDSA )(FDA gave the go ahead to start a Phase 2b trial for EB01, its lead candidate being evaluated for chronic allergic contact dermatitis) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Hologic, Inc. (NASDAQ: HOLX ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 20) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) AMAG Pharmaceuticals, Inc.
   The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge  2019/06/20 11:25:13 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 19) Abbott Laboratories (NYSE: ABT ) CareDx Inc (NASDAQ: CDNA ) CONMED Corporation (NASDAQ: CNMD ) DENTSPLY SIRONA Inc (NASDAQ: XRAY ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Merck & Co., Inc. (NYSE: MRK )(reports suggested that the company is on the look out to find a replacement for its CEO Ken Frazier) Novocure Ltd (NASDAQ: NVCR ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Zynex Inc. (NASDAQ: ZYXI ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 19) Abeona Therapeutics Inc (NASDAQ: ABEO ) CELYAD SA/ADR (NASDAQ: CYAD ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Jaguar Health Inc (NASDAQ: JAGX ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Surface Oncology Inc (NASDAQ: SURF ) Stocks In Focus DiaMedica Drug Found Safe And Effective Against Chronic Kidney Disease DiaMedica Therapeutics Inc (NASDAQ: DMAC ) announced interim results from the Phase 1b study of its DM199, which is being evaluated for moderate-to-severe chronic …

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 コントラビ―・ファ―マシュ―ティカルズ CTRV ContraVir Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)